"Drug-resistant mutants can be transmitted to the patients who havenât been exposed to any antiretroviral drugs, which are called transmitted drug resistance (TDR). TDR is an ongoing public health problem all over the world, may increase the risk of virologic failure following combination anti-retroviral therapy (cART) initiation. Therefore, current HIV treatment guidelines recommend resistance testing at entry into HIV care and at cART initiation. However, the stability of these mutants after the transmission to a new host in the absence of selective drug pressure is not known.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide.
Last date updated on September, 2020